Pholcodine stimulates a dramatic increase of IgE in IgE‐sensitized individuals. A pilot study
- 30 November 2005
- Vol. 61 (1) , 49-55
- https://doi.org/10.1111/j.1398-9995.2005.00933.x
Abstract
A previous study showed a relation between pholcodine (PHO) consumption, prevalence of IgE-sensitization to PHO, morphine (MOR) and suxamethonium (SUX) and anaphylaxis to neuromuscular blocking agents (NMBA). The purpose of this pilot study was to explore the effect on IgE production, in IgE-sensitized and nonsensitized individuals, of exposure to cough syrup and environmental chemicals containing PHO, MOR and SUX related allergenic structures. Serum concentrations of IgE and IgE antibodies to PHO, MOR and SUX allergens measured by ImmunoCAP (Pharmacia Diagnostics, Uppsala, Sweden) were followed after intake of cough syrup, or exposure to confectionary and other household chemicals containing various amounts of substances cross-reacting with PHO, MOR and SUX. Cough syrup containing PHO gave, in sensitized individuals, within 1-2 weeks, an increase of IgE of 60-105 times and of IgE antibodies to PHO, MOR and SUX in the order of 30-80 times. The tested confectionary did not have any similar stimulating effect but seemed to counteract the expected decrease of IgE. No effect was seen in nonsensitized individuals. The PHO stimulated IgE showed a nonspecific binding to ImmunoCAP with common allergens and glycine background ImmunoCAP that was up to 10-fold higher than that of monomeric myeloma-IgE at twice the concentration. It seems as cough syrups containing PHO have a most remarkable IgE boostering effect in persons IgE-sensitized to PHO, MOR and SUX related allergens. Household chemicals containing such allergenic epitopes seem capable of some, minor, stimulation.Keywords
This publication has 13 references indexed in Scilit:
- Passive IgE‐sensitization by blood transfusionAllergy, 2005
- Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectivelyActa Anaesthesiologica Scandinavica, 2005
- The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammationJournal of Allergy and Clinical Immunology, 2005
- T cell responses to recombinant isoforms, synthetic peptides and a mutant variant of Lep d 2, a major allergen from the dust miteLepidoglyphus destructorClinical and Experimental Allergy, 2001
- Rocuronium and anaphylaxis – a statistical challengeActa Anaesthesiologica Scandinavica, 2001
- Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- Substituted ammonium ions as allergenic determinants in drug allergyNature, 1983
- Raised Serum Levels of IgE in Infectious MononucleosisScandinavian Journal of Infectious Diseases, 1972
- In vitro Diagnosis of Atopic AllergyInternational Archives of Allergy and Immunology, 1971
- IMMUNOGLOBULIN LEVELS IN ETHIOPIAN PRESCHOOL CHILDREN WITH SPECIAL REFERENCE TO HIGH CONCENTRATIONS OF IMMUNOGLOBULIN E (IgND)The Lancet, 1968